(Q28270011)

English

3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine

scientific article published on March 1, 1991

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

0 references

3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine (English)

0 references

0 references

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

author name string

D. J. McKenna

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829838

4 December 2022

X. M. Guan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829838

4 December 2022

A. T. Shulgin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1829838

4 December 2022

language of work or name

0 references

publication date

March 1991

0 references

full work available at URL

https://api.elsevier.com/content/article/PII:009130579190005M?httpAccept=text/xml

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

https://api.elsevier.com/content/article/PII:009130579190005M?httpAccept=text/plain

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Pharmacology, Biochemistry and Behavior

0 references

38

0 references

3

0 references

505-12

0 references

Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites

2

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

The rapid uptake and release of [3H]adenosine by rat cerebral cortical synaptosomes

4

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Fenfluramine Metabolism

6

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Reversible and irreversible phases of serotonin depletion by 4-chloroamphetamine

8

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

5-HT1 and 5-HT2 binding characteristics of 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane analogues.

10

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Characterization of [3H]paroxetine binding to rat cortical membranes

11

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

12

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.

13

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

14

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens

15

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.

16

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.

17

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Drug discrimination studies with MDMA and amphetamine

18

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

20

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: evidence for differences in the effects of methamphetamine and amphetamine

21

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Ring-substituted amphetamine interactions with neurotransmitter receptor binding sites in human cortex

23

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals

24

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain

25

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Immediate and long-term effects of p-chloroamphetamine on brain amines

26

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs

29

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

31

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

32

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Psychotomimetic amphetamines: Methoxy 3,4-dialkoxyamphetamines

35

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

3-METHOXY-4,5-METHYLENEDIOXY AMPHETAMINE, A NEW PSYCHOTOMIMETIC AGENT.

36

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

The background and chemistry of MDMA.

38

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Psychotrophic phenylisopropylamines derived from apiole and dillapiole

39

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Animal Pharmacology and Human Psychopharmacology of 3-Methoxy-4,5-Methylenedioxyphenylisopropylamine (MMDA)

40

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Potential misrepresentation of 3,4-methylenedioxyamphetamine (MDA). A toxicological warning

41

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

42

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

A comparison of the neurotoxic potential of methylenedioxyamphetamine (MDA) and its N-methylated and N-ethylated derivatives

43

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine

44

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

46

1 reference

10.1016/0091-3057(91)90005-M

https://api.crossref.org/works/10.1016/0091-3057(91)90005-M

4 December 2022

Identifiers

10.1016/0091-3057(91)90005-M

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28270011&oldid=1784232013"